Yekeduz, E. Et Al. 2021. Nivolumab in metastatic renal cell carcinoma: results from the Turkish Oncology Group Kidney Cancer Consortium database. FUTURE ONCOLOGY , vol.17 , 4861-4869.

Yekeduz, E., Erturk, I., Tural, D., Karadurmus, N., Karakaya, S., Hizal, M., ... Arikan, R.(2021). Nivolumab in metastatic renal cell carcinoma: results from the Turkish Oncology Group Kidney Cancer Consortium database. FUTURE ONCOLOGY , vol.17, 4861-4869.

Yekeduz, EMRE Et Al. "Nivolumab in metastatic renal cell carcinoma: results from the Turkish Oncology Group Kidney Cancer Consortium database," FUTURE ONCOLOGY , vol.17, 4861-4869, 2021

Yekeduz, EMRE Et Al. "Nivolumab in metastatic renal cell carcinoma: results from the Turkish Oncology Group Kidney Cancer Consortium database." FUTURE ONCOLOGY , vol.17, pp.4861-4869, 2021

Yekeduz, E. Et Al. (2021) . "Nivolumab in metastatic renal cell carcinoma: results from the Turkish Oncology Group Kidney Cancer Consortium database." FUTURE ONCOLOGY , vol.17, pp.4861-4869.

@article{article, author={EMRE YEKEDÜZ Et Al. }, title={Nivolumab in metastatic renal cell carcinoma: results from the Turkish Oncology Group Kidney Cancer Consortium database}, journal={FUTURE ONCOLOGY}, year=2021, pages={4861-4869} }